Complete Radiopharmaceutical Therapy Solutions

Learn More

Biomarker Discovery with Spatial Resolution

Explore More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

IO360° 2024

IO360° 2024: Combining Radiopharmaceuticals with Immunotherapy

Learn about Invicro’s portfolio of preclinical and clinical immuno-oncology (IO) capabilities at IO360° meeting booth #24! Fueled by our advanced technology solutions, we have supported the full spectrum of therapeutic modalities – our expertise extends to combining radiopharmaceuticals with immunotherapy and optimizing the development of targeted therapies like antibody drug conjugates.

Let’s Chat

Your Late Phase Imaging Biomarker Partner!

Join us at booth #814 to explore how Invicro’s global clinical imaging core lab has successfully supported 600+ clinical trials driven by scientific and operational excellence, guided by project management expertise, and amplified by extracting crucial data with advanced analytics and artificial intelligence.

Let’s Chat

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now